<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4674</id>
  <title>T3D4620</title>
  <common-name>Urea</common-name>
  <description>Urea is a highly soluble organic compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Urea is formed in a cyclic pathway known simply as the urea cycle. In this cycle, amino groups donated by ammonia and L-aspartate are converted to urea. Urea is essentially a waste product; it has no physiological function. It is dissolved in blood (in humans in a concentration of 2.5 - 7.5 mmol/liter) and excreted by the kidney in the urine. In addition, a small amount of urea is excreted (along with sodium chloride and water) in human sweat.</description>
  <cas>57-13-6</cas>
  <pubchem-id>1176</pubchem-id>
  <chemical-formula>CH4N2O</chemical-formula>
  <weight>60.056</weight>
  <appearance>White powder.</appearance>
  <melting-point>132°C</melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility>545.0 mg/mL</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>10% hydrate skin, 15% accelerate fibrin degradation, 20-30% are antipruritic, break down keratin, decrease the thickness of the stratum corneum and are used in scaling conditions such as ichthysosis, and 40% are proteolytic and may be used to dissolve and peel dystrophic nails.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-09-05T17:15:01Z</created-at>
  <updated-at type="dateTime">2026-04-17T17:48:06Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Urea</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C00086</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>16199</chebi-id>
  <biocyc-id>UREA</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB03904</drugbank-id>
  <pdb-id>URE</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>NC(N)=O</moldb-smiles>
  <moldb-formula>CH4N2O</moldb-formula>
  <moldb-inchi>InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)</moldb-inchi>
  <moldb-inchikey>XSQUKJJJFZCRTK-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">60.0553</moldb-average-mass>
  <moldb-mono-mass type="decimal">60.03236276</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>-2.11</logp>
  <hmdb-id>HMDB00294</hmdb-id>
  <chembl-id>CHEMBL985</chembl-id>
  <chemspider-id>1143</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Ryo Yoshida, Haruhiko Katoh, Seizo Sumida, Ichiki Takemoto, Junya Takahashi, Katsuzo Kamoshita, &amp;#8220;Urea derivatives, and their production and use.&amp;#8221; U.S. Patent US4334912, issued 0000.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003580</chemdb-id>
  <dsstox-id>DTXSID4021426</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin>REACH</stoff-ident-origin>
  <stoff-ident-id>SI00006682</stoff-ident-id>
  <susdat-id>NS00001564</susdat-id>
  <iupac>urea</iupac>
</compound>
